1. TBHQ Alleviated Endoplasmic Reticulum Stress-Apoptosis and Oxidative Stress by PERK-Nrf2 Crosstalk in Methamphetamine-Induced Chronic Pulmonary Toxicity
   Yun Wang et al, 2017, Oxidative Medicine and Cellular Longevity CrossRef
2. Multimodal actions of the phytochemical sulforaphane suppress both AR and AR-V7 in 22Rv1 cells: Advocating a potent pharmaceutical combination against castration-resistant prostate cancer
   Namrata Khurana et al, 2017, Oncology Reports CrossRef
3. A Patient-Derived Cell Atlas Informs Precision Targeting of Glioblastoma
   Patrik Johansson et al, 2020, Cell Reports CrossRef
4. Autophagic sequestration of SQSTM1 disrupts the aggresome formation of ubiquitinated proteins during proteasome inhibition
   Chenliang Zhang et al, 2022, Cell Death & Disease CrossRef
5. In silico analysis of the potential mechanism of telocinobufagin on breast cancer MCF-7 cells
   Yi-wu Dang et al, 2018, Pathology - Research and Practice CrossRef
6. Aggresomes predict poor outcomes and implicate proteostasis in the pathogenesis of pediatric choroid plexus tumors
   Nada Amer et al, 2021, Journal of Neuro-Oncology CrossRef
7. 2-Aminoethoxydiphenylborane sensitizes anti-tumor effect of bortezomib via suppression of calcium-mediated autophagy
   Yuan Qing Qu et al, 2018, Cell Death & Disease CrossRef
8. Targeting the unfolded protein response in head and neck and oral cavity cancers
   Daniel W. Cole et al, 2019, Experimental Cell Research CrossRef
9. Combination of Second-Generation Proteasome Inhibitor Carfilzomib with Bortezomib in Four Different Breast Cancer Cell Lines
   Ergul Mutlu Altundag et al, 2022, Anti-Cancer Agents in Medicinal Chemistry CrossRef
10. Positioning of proteasome inhibitors in therapy of solid malignancies
    Margot S. F. Roeten et al, 2018, Cancer Chemotherapy and Pharmacology CrossRef
11. Induction of synergistic non‑apoptotic cell death by simultaneously targeting proteasomes with bortezomib and histone deacetylase 6 with ricolinostat in head and neck tumor cells
    Kazuhiro Hattori et al, 2021, Oncology Letters CrossRef
12. Gemcitabine, vinorelbine and cyclooxygenase inhibitors in the treatment of glioblastoma. Ultrastructural analyses in C6 glioma in vitro
    İlhan Elmaci et al, 2019, Tissue and Cell CrossRef
13. Novel Indole–Chalcone Derivative-Ligated Platinum(IV) Prodrugs Attenuate Cisplatin Resistance in Lung Cancer through ROS/ER Stress and Mitochondrial Dysfunction
    Zhikun Liu et al, 2023, Journal of Medicinal Chemistry CrossRef
14. Azithromycin, a potent autophagy inhibitor for cancer therapy, perturbs cytoskeletal protein dynamics
    Naoharu Takano et al, 2023, British Journal of Cancer CrossRef
15. Amino acid starvation culture condition sensitizes EGFR-expressing cancer cell lines to gefitinib-mediated cytotoxicity by inducing atypical necroptosis
    Yu Saito et al, 2018, International Journal of Oncology CrossRef
16. Randomized phase II clinical trial and biomarker analysis of paclitaxel plus epirubicin versus vinorelbine plus epirubicin as neoadjuvant chemotherapy in locally advanced HER2-negative breast cancer with TEKT4 variations
    Yi-Zhou Jiang et al, 2021, Breast Cancer Research and Treatment CrossRef
17. ClC5 Decreases the Sensitivity of Multiple Myeloma Cells to Bortezomib via Promoting Prosurvival Autophagy
    Huimin Zhang et al, 2018, Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics CrossRef
18. Designing an effective drug combination for ER stress loading in cancer therapy using a real-time monitoring system
    Hiromi Kazama et al, 2018, Biochemical and Biophysical Research Communications CrossRef
19. Vinorelbine’s anti-tumor actions may depend on the mitotic apoptosis, autophagy and inflammation: hypotheses with implications for chemo-immunotherapy of advanced cancers and pediatric gliomas
    Meric A. Altinoz et al, 2018, Journal of Chemotherapy CrossRef